Galectin-3 secreted by human umbilical cord blood-derived mesenchymal stem cells reduces amyloid-β42 neurotoxicity in vitro

FEBS Letters

Volumn 584, Issue 16, 2010, Pages 3601-3608

  Kim, Ju Yeon ^a,b   Kim, Dong Hyun ^a   Kim, Dal Soo ^a   Kim, Ji Hyun ^a   Jeong, Sang Young ^a   Jeon, Hong Bae ^a   Lee, Eun Hui ^b   Yang, Yoon Sun ^a   Oh, Wonil ^a   Chang, Jong Wook ^a  

^a MEDIPOST Co Ltd   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Amyloid ; Galectin 3; HUCB MSC; Neuroprotection

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CASPASE 3; GALECTIN 3; SMALL INTERFERING RNA;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL SURVIVAL; COCULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; EMBRYO; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYMAL STEM CELL; NERVE CELL; NERVE CELL NECROSIS; NEUROBLASTOMA CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; UMBILICAL CORD BLOOD; UPREGULATION;

AMYLOID BETA-PROTEIN; ANIMALS; CELL LINE; CELLS, CULTURED; COCULTURE TECHNIQUES; FETAL BLOOD; GALECTIN 3; GENE KNOCKDOWN TECHNIQUES; HUMANS; MESENCHYMAL STEM CELLS; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; PEPTIDE FRAGMENTS; RATS; RNA, SMALL INTERFERING; UP-REGULATION;

RATTUS;

EID: 77955653449     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.07.028     Document Type: Article

References (30)

1. Wang M., Yang Y., Yang D., Luo F., Liang W., Guo S., Xu J. The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro. Immunology 2009, 126:220-232.
2. Oh W., Kim D.S., Yang Y.S., Lee J.K. Immunological properties of umbilical cord blood-derived mesenchymal stromal cells. Cell Immunol. 2008, 251:116-123.
3. Kim D.S., Kim J.H., Lee J.K., Choi S.J., Kim J.S., Jeun S.S., Oh W., Yang Y.S., Chang J.W. Overexpression of CXC chemokine receptors is required for the superior glioma-tracking property of umbilical cord blood-derived mesenchymal stem cells. Stem Cells Dev. 2009, 18:511-519.
4. Kim S.M., Lim J.Y., Park S.I., Jeong C.H., Oh J.H., Jeong M., Oh W., Park S.H., Sung Y.C., Jeun S.S. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma. Cancer Res. 2008, 68:9614-9623.
5. Lee H., Jin H.K., Bae J.S. Human umbilical cord blood-derived mesenchymal stem cells improve neurological abnormalities of Niemann-Pick type C mouse by modulation of neuroinflammatory condition. J. Vet. Med. Sci. 2010, [Epub ahead of print].
6. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 2004, 430:631-639.
7. Smith M.A. Alzheimer disease. Int. Rev. Neurobiol. 1998, 42:1-54.
8. Yamasaki T.R., Blurton-Jones M., Morrissette D.A., Kitazawa M., Oddo S., LaFerla F.M. Neural stem cells improve memory in an inducible mouse model of neuronal loss. J. Neurosci. 2007, 27:11925-11933.
9. Blurton-Jones M., Kitazawa M., Martinez-Coria H., Castello N.A., Muller F.J., Loring J.F., Yamasaki T.R., Poon W.W., Green K.N., LaFerla F.M. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc. Natl. Acad. Sci. USA 2009, 106:13594-13599.
10. Lee J.K., Jin H.K., Endo S., Schuchman E.H., Carter J.E., Bae J.S. Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer's disease mice by modulation of immune responses. Stem Cell 2010, 28:329-343.
11. Jin H.J., Nam H.Y., Bae Y.K., Kim S.Y., Im I.R., Oh W., Yang Y.S., Choi S.J., Kim S.W. GD2 expression is closely associated with neuronal differentiation of human umbilical cord blood-derived mesenchymal stem cells. Cell. Mol. Life Sci. 2010, [Epub ahead of print].
12. Nickel W. The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes. Eur. J. Biochem. 2003, 270:2109-2119.
13. Pesheva P., Kuklinski S., Schmitz B., Probstmeier R. Galectin-3 promotes neural cell adhesion and neurite growth. J. Neurosci. Res. 1998, 54:639-654.
14. Block G.J., Ohkouchi S., Fung F., Frenkel J., Gregory C., Pochampally R., DiMattia G., Sullivan D.E., Prockop D.J. Multipotent stromal cells are activated to reduce apoptosis in part by upregulation and secretion of stanniocalcin-1. Stem Cells 2009, 27:670-681.
15. Lee R.H., Pulin A.A., Seo M.J., Kota D.J., Ylostalo J., Larson B.L., Semprun-Prieto L., Delafontaine P., Prockop D.J. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009, 5:54-63.
16. Hsu D.K., Chen H.Y., Liu F.T. Galectin-3 regulates T-cell functions. Immunol. Rev. 2009, 230:114-127.
17. Yang R.Y., Hsu D.K., Liu F.T. Expression of galectin-3 modulates T-cell growth and apoptosis. Proc. Natl. Acad. Sci. USA 1996, 93:6737-6742.
18. Hughes R.C. Secretion of the galectin family of mammalian carbohydrate-binding proteins. Biochim. Biophys. Acta 1999, 1473:172-185.
19. Stowell S.R., Qian Y., Karmakar S., Koyama N.S., Dias-Baruffi M., Leffler H., McEver R.P., Cummings R.D. Differential roles of galectin-1 and galectin-3 in regulating leukocyte viability and cytokine secretion. J. Immunol. 2008, 180:3091-3102.
20. Cortegano I., del Pozo V., Cardaba B., de Andres B., Gallardo S., del Amo A., Arrieta I., Jurado A., Palomino P., Liu F.T., Lahoz C. Galectin-3 down-regulates IL-5 gene expression on different cell types. J. Immunol. 1998, 161:385-389.
21. Sato S., Hughes R.C. Control of Mac-2 surface expression on murine macrophage cell lines. Eur. J. Immunol. 1994, 24:216-221.
22. Grossmann J. Molecular mechanisms of " detachment-induced apoptosis-Anoikis" Apoptosis 2002, 7:247-260.
23. Holmes C., Boche D., Wilkinson D., Yadegarfar G., Hopkins V., Bayer A., Jones R.W., Bullock R., Love S., Neal J.W., Zotova E., Nicoll J.A. Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet 2008, 372:216-223.
24. Lim J.Y., Park S.I., Oh J.H., Kim S.M., Jeong C.H., Jun J.A., Lee K.S., Oh W., Lee J.K., Jeun S.S. Brain-derived neurotrophic factor stimulates the neural differentiation of human umbilical cord blood-derived mesenchymal stem cells and survival of differentiated cells through MAPK/ERK and PI3K/Akt-dependent signaling pathways. J. Neurosci. Res. 2008, 86:2168-2178.
25. Chung D.J., Choi C.B., Lee S.H., Kang E.H., Lee J.H., Hwang S.H., Han H., Lee J.H., Choe B.Y., Lee S.Y., Kim H.Y. Intraarterially delivered human umbilical cord blood-derived mesenchymal stem cells in canine cerebral ischemia. J. Neurosci. Res. 2009, 87:3554-3567.
26. Tio M., Tan K.H., Lee W., Wang T.T., Udolph G. Roles of db-cAMP, IBMX and RA in aspects of neural differentiation of cord blood derived mesenchymal-like stem cells. PLoS One 2010, 5:e9398.
27. Glass C.K., Saijo K., Winner B., Marchetto M.C., Gage F.H. Mechanisms underlying inflammation in neurodegeneration. Cell 2010, 14:918-934.
28. Aggarwal S., Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005, 105:1815-1822.
29. Oh J.Y., Kim M.K., Shin M.S., Lee H.J., Ko J.H., Wee W.R., Lee J.H. The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury. Stem cells 2008, 26:1047-1055.
30. Kim J.Y., Jeon H.B., Yang Y.S., Oh W., Chang J.W. Application of human umbilical cord blood-derived mesenchymal stem cells in disease models. World J. Stem Cells 2010, 2:34-38.